Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
bicalutamide (casodex) (1 trial)
docetaxel (taxotere) (2 trials)
Prostatic Neoplasms (Phase 3)
Trials (3 total)
Trial APIs (2 total)